Previous 10 | Next 10 |
Major earnings expected before the bell on Thursday include: Arrival ( ARVL ) Brookfield Asset Management ( BAM ) Cardinal Health ( CAH ) Hanesbrands ( HBI ) Himax Technologies ( HIMX ) For further details see: Notable earnings before Thur...
Biotech stocks are notoriously volatile, and reinforcing this on Tuesday was the performance of the clinical-stage company CorMedix (NASDAQ: CRMD) . A key pipeline product was again rejected by a top regulator, and as a result the shares were in free fall. They closed the day down m...
Gainers: BBQ Holdings ( BBQ ) +46% . Verona Pharma ( VRNA ) +41% . Mersana Therapeutics ( MRSN ) +31% . SAI.TECH Global ( SAI ) +30% . Atara Biotherapeutics ( ATRA ) +28% . PubMatic ( PUBM ) +24% . RumbleON ( RM...
Gainers: Verona Pharma VRNA +87% . Mersana Therapeutics ( MRSN ) +38% . GoodRx Holdings ( GDRX ) +19% . Atara Biotherapeutics ( ATRA ) +22% . Heron Therapeutics HRTX +16% . Losers: CorMedix ( CRMD ) -56% . Qu...
CorMedix CRMD -61% after FDA again rejects CorMedix's application for lead candidate DefenCath . Turtle Beach HEAR -32% on Q2 earnings miss . Novavax NVAX -31% on Q2 earnings release . Medicenna Therapeutics MDNA -29% on launch of units offeri...
CorMedix ( NASDAQ: CRMD ) on Monday said its new drug application for its antibacterial and antifungal solution DefenCath had been rejected by the U.S. FDA for a second time, sending its shares plunging 60.1% to $3 after hours. The second rejection of the new drug ...
BERKELEY HEIGHTS, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced updates related to the ...
BERKELEY HEIGHTS, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report...
Gainers: Direct Digital Holdings ( DRCT ) +81% . ToughBuilt Industries ( TBLT ) +54% . Stronghold Digital Mining ( SDIG ) +42% . Calithera Biosciences ( CALA ) +27% . CorMedix ( CRMD ) +23% . Allakos ( ALLK ) +22% ...
SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of the CorMedix Inc. (NASDAQ: CRMD). Investors, who purchased shares of CorMedix Inc. (NASDAQ: CRMD) prior to July 2020 and c...
News, Short Squeeze, Breakout and More Instantly...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BERKELEY HEIGHTS, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has commenced commercialization of DefenCath ® (tauroli...
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the U.S. Food and Drug Administration (FDA) has...